About this trial
The goal of this clinical trial is to learn if elevating postoperative blood pressure works to improve prognosis in aneurysmal subarachnoid hemorrhage (aSAH) patients. The main questions it aims to answer are:
Does elevating postoperative blood pressure can improve the prognosis of aSAH ? What safety problems do participants have when received elevating blood pressure measurement?
Participants will:
Receive elevating or lowering blood pressure therapy in 72 hours after randomization, in order to maintain blood pressure within predefined target ranges Receive follow-up at 30 days, 90 days, and 180 days after randomization
Eligibility criteria
Qualifiers
1) Aged 18-75 years;
Disqualifiers
1) Presence of untreated intracranial aneurysms with rupture risk;
Trial design
Treatments tested in this trial
- Blood pressure was regulated within the normal target management range
- Blood pressure was regulated within the elevated target management range
Treatment groups
Sponsors and collaborators
Beijing Tiantan Hospital
Lead sponsor
Development Center for Medical Science & Technology National Health Commission of the People's Republic of China
Collaborator
Tianjin Medical University General Hospital
Collaborator